More than a third of people who self-identify as having a smell disorder have had at least one gas safety scare in the last five years, according to new research.
UniQure reaches milestone, Idorsia’s bridge financing extends runway, and Pharvaris scores $70M placement
UniQure, the developer of Hemgenix, the $3.5 million hemophilia B gene therapy licensed to Australia’s CSL Behring, announced Tuesday morning that it hit a $100
June 21, 2023